The cost of research and development of 35 listed pharmaceutical companies was disclosed, up to 373 million yuan.
Photo source: 16sucai.
This article is reproduced from "medicine local station", original title: 35 pharmaceutical companies research and development cost exposure!
On March 20th, the medical local station learned from the data of tonghua shun, 35 pharmaceutical companies have announced the r&d cost in 2017.
Among the 35 publicly listed pharmaceutical companies, the highest r&d cost was baiyunshan, with 373 million yuan, accounting for 1.78% of the revenue. Second, changchun high and new 349 million yuan, China resources 39326 million yuan, respectively accounting for 8.5 percent, 2.93 percent.
In addition to the above three drug firms, research and development costs in the drug companies and 11 of one hundred million yuan of above, including market, China resources double crane, global pharmaceutical industry, the company, Harbin pharmaceutical co, shengwalunding paying court to equity, immortality biological pharmaceutical co., China, double heron pharmaceutical, sunflower pharmaceutical, rong tai health.
The cost of research and development of 35 listed pharmaceutical companies was disclosed, up to 373 million yuan.
All the words, pictures and audio-visual materials of "source: biological exploration" are listed on this website. All rights are owned by biological exploration, and the reproduction of other platforms shall be authorized. All this net reprint articles for the purpose of the information, and indicate the source and the author, the media do not want to be reproduced or individuals can contact us (editor@biodiscover.com), we will delete immediately. All articles represent the author's views and do not represent the position of the author.